LAURUSLABS

Laurus Labs Share Price

₹634.00 +5.95 (0.95%)

21 Apr, 2025 10:33

SIP TrendupStart SIP in LAURUSLABS

Start SIP

Performance

  • Low
  • ₹627
  • High
  • ₹636
  • 52 Week Low
  • ₹385
  • 52 Week High
  • ₹646
  • Open Price₹628
  • Previous Close₹628
  • Volume450,759

Investment Returns

  • Over 1 Month + 4.89%
  • Over 3 Month + 8.52%
  • Over 6 Month + 33.43%
  • Over 1 Year + 48.65%
SIP Lightning

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 170.7
  • PEG Ratio
  • 26
  • Market Cap Cr
  • 34,189
  • P/B Ratio
  • 8.3
  • Average True Range
  • 24.98
  • EPS
  • 3.71
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 6.36
  • RSI
  • 59.05
  • MFI
  • 53.79

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹634.00
+ 5.95 (0.95%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹599.71
  • 50 Day
  • ₹587.44
  • 100 Day
  • ₹568.57
  • 200 Day
  • ₹532.64

Resistance and Support

629.02 Pivot Speed
  • R3 644.88
  • R2 639.92
  • R1 633.98
  • S1 623.08
  • S2 618.12
  • S3 612.18

What's your outlook on Laurus Labs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 5,273.33 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 5% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 20% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-24 Audited Results & Interim Dividend
2025-01-24 Quarterly Results
2024-10-24 Quarterly Results & Interim Dividend
2024-07-25 Quarterly Results
2024-04-25 Audited Results & Interim Dividend
Date Purpose Remarks
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-05-10 INTERIM Rs.1.20 per share(60%)Interim Dividend
2022-11-04 INTERIM Rs.0.80 per share(40%)Interim Dividend
View More
Date Purpose Remarks
2020-09-30 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.62%
6.88%
3.63%
25.51%
0%
23.64%
12.72%

About Laurus Labs

  • NSE Symbol
  • LAURUSLABS
  • BSE Symbol
  • 540222
  • ISIN
  • INE947Q01028

Similar Stocks to Laurus Labs

Laurus Labs FAQs

Laurus Labs share price is ₹634 As on 21 April, 2025 | 10:19

The Market Cap of Laurus Labs is ₹34188.6 Cr As on 21 April, 2025 | 10:19

The P/E ratio of Laurus Labs is 170.7 As on 21 April, 2025 | 10:19

The PB ratio of Laurus Labs is 8.3 As on 21 April, 2025 | 10:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23